Infliximab response associates with radiologic findings in bio-naïve Crohn’s disease

OBJECTIVES: Since a reliable model for predicting infliximab (IFX) benefits in bio-naïve Crohn’s disease (CD) is still lacking, we constructed a magnetic resonance enterography (MRE)-based model to predict the risk of loss of response to IFX in bio-naïve patients with CD. METHODS: This retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Yueying, Chen, Jing, Feng, Qi, Feng, Jun, Shen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Magnetic Resonance
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326128/
https://www.ncbi.nlm.nih.gov/pubmed/36928565
http://dx.doi.org/10.1007/s00330-023-09542-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326128/
https://www.ncbi.nlm.nih.gov/pubmed/36928565
http://dx.doi.org/10.1007/s00330-023-09542-y

Ejemplares similares